MA33324B1 - Bioessais de contrôle qualité pour des produits nutraceutiques et médicinaux - Google Patents
Bioessais de contrôle qualité pour des produits nutraceutiques et médicinauxInfo
- Publication number
- MA33324B1 MA33324B1 MA34343A MA34343A MA33324B1 MA 33324 B1 MA33324 B1 MA 33324B1 MA 34343 A MA34343 A MA 34343A MA 34343 A MA34343 A MA 34343A MA 33324 B1 MA33324 B1 MA 33324B1
- Authority
- MA
- Morocco
- Prior art keywords
- agent
- substance
- supplement
- bioessais
- nutraceutical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La présente invention concerne des bioessais pour détecter la capacité d'un échantillon d'une substance alimentaire, d'un supplément nutritionnel, d'un agent thérapeutique et/ou d'un agent préventif de maladie par rapport à celle d'un second échantillon d'une telle substance, supplément et/ou agent à inhiber, réguler à la hausse ou moduler autrement l'initiation de la traduction, et présenter ainsi un effet curatif et/ou préventif d'une maladie chez un humain et/ou un animal qui consomme de tels substance, supplément et/ou agent ou auquel de tels substance, supplément et/ou agent sont administrés.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17033009P | 2009-04-17 | 2009-04-17 | |
PCT/US2010/031393 WO2010121131A2 (fr) | 2009-04-17 | 2010-04-16 | Bioessais de contrôle qualité pour des produits nutraceutiques et médicinaux |
Publications (1)
Publication Number | Publication Date |
---|---|
MA33324B1 true MA33324B1 (fr) | 2012-06-01 |
Family
ID=42983164
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA34343A MA33324B1 (fr) | 2009-04-17 | 2010-04-16 | Bioessais de contrôle qualité pour des produits nutraceutiques et médicinaux |
Country Status (20)
Country | Link |
---|---|
US (2) | US8999646B2 (fr) |
EP (1) | EP2419541B1 (fr) |
JP (2) | JP2012523837A (fr) |
KR (2) | KR101769569B1 (fr) |
CN (2) | CN102459637B (fr) |
AU (1) | AU2010236247B2 (fr) |
BR (1) | BRPI1006624B1 (fr) |
CA (1) | CA2758546C (fr) |
CL (1) | CL2011002566A1 (fr) |
CO (1) | CO6460755A2 (fr) |
DK (1) | DK2419541T3 (fr) |
ES (1) | ES2629425T3 (fr) |
HU (1) | HUE033579T2 (fr) |
MA (1) | MA33324B1 (fr) |
MX (1) | MX337517B (fr) |
PE (2) | PE20160883A1 (fr) |
PL (1) | PL2419541T3 (fr) |
PT (1) | PT2419541T (fr) |
RU (2) | RU2642292C1 (fr) |
WO (1) | WO2010121131A2 (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2013292266B2 (en) | 2012-07-20 | 2019-01-03 | President And Fellows Of Harvard College | Cell based quality control bioassays for nutriceutical and medicinal products |
US11426566B2 (en) | 2016-12-14 | 2022-08-30 | Biora Therapeutics, Inc. | Treatment of a disease of the gastrointestinal tract with a TLR modulator |
WO2018126499A1 (fr) * | 2017-01-05 | 2018-07-12 | 深圳迈瑞生物医疗电子股份有限公司 | Procédé de préparation de particule simulée de réticulocytes et particule simulée de plaquettes, et matériau de contrôle de qualité |
CN111378707B (zh) * | 2018-12-28 | 2022-06-21 | 康码(上海)生物科技有限公司 | 一种体外无细胞蛋白合成体系及其应用 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2041256C1 (ru) * | 1993-09-17 | 1995-08-09 | Акционерное общество закрытого типа "Эри Марин" | Способ переработки рыбьего жира с получением концентрата этиловых эфиров полиненасыщенных жирных кислот |
US5955269A (en) * | 1996-06-20 | 1999-09-21 | Rutgers, The State University Of New Jersey | Methods of screening foods for nutraceuticals |
US20020018989A1 (en) | 1996-11-07 | 2002-02-14 | Albert Beaufour | Method of identifying pharmaceuticals from plant extracts |
IL144653A0 (en) * | 1999-02-10 | 2002-05-23 | Oxford Natural Products Plc | Process for quality control and standardisation of medicinal plant products |
WO2002057496A2 (fr) | 2001-01-18 | 2002-07-25 | Socratech L.L.C. | Etablissement du profil de l'expression genetique de l'endothelium dans la maladie d'alzheimer |
GB0205186D0 (en) * | 2002-03-06 | 2002-04-17 | Molecularnature Ltd | Method for monitoring the quality of a herbal medicine |
WO2008008333A2 (fr) * | 2006-07-11 | 2008-01-17 | President And Fellows Of Harvard College | Bioessais pour le contrôle qualité de produits nutraceutiques qui inhibent, régulent à la hausse ou modulent d'une autre manière l'initiation de la traduction |
EP2435040A2 (fr) | 2009-05-28 | 2012-04-04 | President and Fellows of Harvard College | Composés de n,n'-diarylurée et de n,n'-diarylthiourée utilisés en tant qu'inhibiteurs de l'initiation de la traduction |
-
2010
- 2010-04-16 PL PL10765259T patent/PL2419541T3/pl unknown
- 2010-04-16 CN CN201080026610.9A patent/CN102459637B/zh active Active
- 2010-04-16 HU HUE10765259A patent/HUE033579T2/hu unknown
- 2010-04-16 AU AU2010236247A patent/AU2010236247B2/en active Active
- 2010-04-16 DK DK10765259.6T patent/DK2419541T3/da active
- 2010-04-16 EP EP10765259.6A patent/EP2419541B1/fr active Active
- 2010-04-16 MA MA34343A patent/MA33324B1/fr unknown
- 2010-04-16 KR KR1020167030669A patent/KR101769569B1/ko active IP Right Grant
- 2010-04-16 PT PT107652596T patent/PT2419541T/pt unknown
- 2010-04-16 MX MX2011010966A patent/MX337517B/es active IP Right Grant
- 2010-04-16 PE PE2016000537A patent/PE20160883A1/es unknown
- 2010-04-16 RU RU2015145864A patent/RU2642292C1/ru active
- 2010-04-16 CN CN201610304364.8A patent/CN105969847B/zh active Active
- 2010-04-16 ES ES10765259.6T patent/ES2629425T3/es active Active
- 2010-04-16 US US13/264,086 patent/US8999646B2/en active Active
- 2010-04-16 JP JP2012505958A patent/JP2012523837A/ja active Pending
- 2010-04-16 RU RU2011141197/10A patent/RU2570626C2/ru active
- 2010-04-16 PE PE2011001809A patent/PE20120793A1/es not_active Application Discontinuation
- 2010-04-16 WO PCT/US2010/031393 patent/WO2010121131A2/fr active Application Filing
- 2010-04-16 BR BRPI1006624-1A patent/BRPI1006624B1/pt not_active IP Right Cessation
- 2010-04-16 KR KR1020117027437A patent/KR101674626B1/ko active IP Right Grant
- 2010-04-16 CA CA2758546A patent/CA2758546C/fr active Active
-
2011
- 2011-10-14 CL CL2011002566A patent/CL2011002566A1/es unknown
- 2011-11-11 CO CO11154114A patent/CO6460755A2/es not_active Application Discontinuation
-
2015
- 2015-03-13 US US14/657,537 patent/US9410946B2/en active Active
- 2015-08-19 JP JP2015161833A patent/JP6185965B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Iwatani et al. | Functional food products in Japan: A review | |
Maria Martone et al. | Treating sarcopenia in older and oldest old | |
Stein et al. | Efficacy of pregabalin in depressive symptoms associated with generalized anxiety disorder: a pooled analysis of 6 studies | |
Lin et al. | (−)-Epigallocatechin gallate inhibition of osteoclastic differentiation via NF-κB | |
Koopman et al. | Aging, exercise, and muscle protein metabolism | |
EP3318262A3 (fr) | Composition pour prévenir ou traiter une maladie osseuse, l'obésité et des maladies métaboliques lipidiques | |
Yin et al. | Effects of Lysine deficiency and Lys‐Lys dipeptide on cellular apoptosis and amino acids metabolism | |
BRPI0818079B8 (pt) | composição de lipídeo | |
Hamidi et al. | Vitamin K and musculoskeletal health in postmenopausal women | |
Fayemi et al. | Targeting the pains of food insecurity and malnutrition among internally displaced persons with nutrient synergy and analgesics in organ meat | |
Kundam et al. | Bioactive compounds in fish and their health benefits | |
Negro et al. | Effects of 12 weeks of essential amino acids (EAA)-based multi-ingredient nutritional supplementation on muscle mass, muscle strength, muscle power and fatigue in healthy elderly subjects: a randomized controlled double-blind study | |
UA88165C2 (en) | Use of trisubstituted benzopyranones | |
Onaolapo et al. | Glutamate and depression: Reflecting a deepening knowledge of the gut and brain effects of a ubiquitous molecule | |
MA33324B1 (fr) | Bioessais de contrôle qualité pour des produits nutraceutiques et médicinaux | |
MA32347B1 (fr) | Gelule pour la prévention de maladies cardiovasculaires | |
Xu et al. | The bioactive com-pounds in medicinal mushrooms have potential protective effects against neu-rodegenerative diseases | |
BRPI0507482A (pt) | combinação de (a) um inibidor de dna topoisomerase e (b) um inibidor de iap | |
Nakanishi et al. | Novel immunomodulatory effects of phytanic acid and its related substances in mice | |
Rosenfeld et al. | Nutrition and dietary supplements in motor neuron disease | |
EP3318251A3 (fr) | Composition pour prévenir ou traiter l'obésité ou une maladie métabolique lipidique | |
Słupski et al. | Role of copper in depression. Relationship with ketamine treatment | |
Yu et al. | Curcumin Ameliorates Heat-Induced Injury through NADPH Oxidase–Dependent Redox Signaling and Mitochondrial Preservation in C2C12 Myoblasts and Mouse Skeletal Muscle | |
Lawler et al. | Effect of combined fish oil & Curcumin on murine skeletal muscle morphology and stress response proteins during mechanical unloading | |
Liu et al. | Advances in nutritional supplementation for sarcopenia management |